Revelation Biosciences Inc (REVB) Stock Price, Quote & News

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology

Sector: Healthcare

Phone: (650) 800-3717

Website: www.revbiosciences.com

Address:

4660 La Jolla Village Drive, Suite 100, San Diego, United States

lookgoodplaygood22 Jul. 6 at 8:46 PM

$REVB let em chase…..

0 · Reply

thaboss8854 Jul. 6 at 4:34 PM

$REVB another thing is it has a short interst of 7.71%. Next week could be a blood bath for them. The first short to cover will be smart. And those saying a healthy company doesn't need a reverse split, of course this company isn't healthy. It lost a lot of money then they failed their phase 3 allergy drug. So now its make it or break it situation. Their Gemini drug will determine their fate, and it seems to not be bad so far.

0 · Reply

ONLYPHARMS Jul. 6 at 9:22 AM

$REVB healthy companies do not need reverse splits this one has done 3 in the last 2 years

1 · Reply

lookgoodplaygood22 Jul. 5 at 3:38 PM

$REVB primed this week. Low float. PR bout to drop. 1-3 R/S Monday is perfect setup. Management isn’t stupid.

0 · Reply

Evissamwohs Jul. 5 at 3:58 AM

$REVB It appears management is only concerned about fattening their pocket book and not about diluting their shareholders! It’s only obvious with three reverse splits in last 18 months! 💩 💩💩

0 · Reply

lookgoodplaygood22 Jul. 4 at 7:05 PM

$REVB yep, not your normal R/s scenario with only 1-3. It’s strategic. She’s going to fly.

0 · Reply

thaboss8854 Jul. 4 at 4:12 PM

$REVB so reverse split, share the news, 15x and become worth 30m. Raise some funds for phase 2 or be acquired or partnered with someone. But anyways the coming weeks are gonna be super fun.

0 · Reply

SkyLonger Jul. 4 at 1:10 PM

$REVB happy 4th 🎇🎆 Monday we will see this @ $2.28 post spilt, hopefully traction/results/news/BO/etc... soon after to 100%-300% range ✨️🚀💥🤙

1 · Reply

chonkybottomfeeder Jul. 3 at 10:43 PM

$REVB deal? Or nah

0 · Reply

Zstock1981 Jul. 3 at 9:16 PM

$REVB tomorrow will open 3$ or 0,30$????

4 · Reply

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

May 29, 2025, 4:05 PM EDT - 5 weeks ago

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 5 weeks ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 23, 2025, 4:05 PM EDT - 6 weeks ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 8, 2025, 4:15 PM EDT - 2 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Apr 29, 2025, 9:00 AM EDT - 2 months ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Mar 17, 2025, 6:00 AM EDT - 3 months ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 13, 2025, 6:00 AM EDT - 4 months ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 6, 2025, 4:15 PM EST - 4 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Feb 26, 2025, 6:00 AM EST - 4 months ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 24, 2025, 6:00 AM EST - 4 months ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Jan 24, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 21, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 13, 2025, 6:00 AM EST - 6 months ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 6, 2025, 6:00 AM EST - 6 months ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Dec 3, 2024, 8:38 AM EST - 7 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 2, 2024, 6:00 AM EST - 7 months ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Nov 12, 2024, 6:00 AM EST - 8 months ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 8, 2024, 4:15 PM EST - 8 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Sep 24, 2024, 6:00 AM EDT - 10 months ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Aug 21, 2024, 5:30 PM EDT - 11 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 9, 2024, 4:15 PM EDT - 11 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Jun 24, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 13, 2024, 9:21 AM EDT - 1 year ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

May 10, 2024, 4:52 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Mar 22, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 13, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Mar 4, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Feb 13, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Feb 9, 2024, 8:35 AM EST - 1 year ago

Top 5 Health Care Stocks That Are Preparing To Pump In February

CNSP GILD ZLAB

Feb 5, 2024, 4:41 PM EST - 1 year ago

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Feb 1, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Jan 30, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Jan 23, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

Nov 13, 2023, 4:05 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Oct 12, 2023, 9:00 AM EDT - 1 year ago

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

Oct 4, 2023, 9:00 AM EDT - 1 year ago

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

Oct 2, 2023, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

Aug 11, 2023, 4:10 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023

Jun 29, 2023, 9:00 AM EDT - 2 years ago

REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders

Jun 12, 2023, 4:15 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional Proposal

May 22, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress

Mar 30, 2023, 5:42 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress

Mar 13, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

Mar 6, 2023, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference

Feb 13, 2023, 4:20 PM EST - 2 years ago

Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering

Feb 9, 2023, 9:42 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering

Feb 7, 2023, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300

Jan 31, 2023, 12:00 PM EST - 2 years ago

Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders

lookgoodplaygood22 Jul. 6 at 8:46 PM

$REVB let em chase…..

0 · Reply

thaboss8854 Jul. 6 at 4:34 PM

0 · Reply

ONLYPHARMS Jul. 6 at 9:22 AM

$REVB healthy companies do not need reverse splits this one has done 3 in the last 2 years

1 · Reply

lookgoodplaygood22 Jul. 5 at 3:38 PM

$REVB primed this week. Low float. PR bout to drop. 1-3 R/S Monday is perfect setup. Management isn’t stupid.

0 · Reply

Evissamwohs Jul. 5 at 3:58 AM

0 · Reply

lookgoodplaygood22 Jul. 4 at 7:05 PM

$REVB yep, not your normal R/s scenario with only 1-3. It’s strategic. She’s going to fly.

0 · Reply

thaboss8854 Jul. 4 at 4:12 PM

$REVB so reverse split, share the news, 15x and become worth 30m. Raise some funds for phase 2 or be acquired or partnered with someone. But anyways the coming weeks are gonna be super fun.

0 · Reply

SkyLonger Jul. 4 at 1:10 PM

$REVB happy 4th 🎇🎆 Monday we will see this @ $2.28 post spilt, hopefully traction/results/news/BO/etc... soon after to 100%-300% range ✨️🚀💥🤙

1 · Reply

chonkybottomfeeder Jul. 3 at 10:43 PM

$REVB deal? Or nah

0 · Reply

Zstock1981 Jul. 3 at 9:16 PM

$REVB tomorrow will open 3$ or 0,30$????

4 · Reply

AZOZ Jul. 3 at 11:35 AM

Oversold idea under $1 dollar 💡 $HCAI $REVB $IVF $FGL $CIIT

0 · Reply

ONLYPHARMS Jul. 3 at 1:09 AM

$REVB they didnt need to split would have over a year with 2 extensions… this smells like manipulation bymanagment

3 · Reply

lookgoodplaygood22 Jul. 2 at 8:28 PM

$REVB what reverse split? Smart money bought the dip yesterday and today while retail dumped on panic. Stay for a while, don’t be a retail dumper…there’s plenty of toilet paper on the shelves…..it’s coming. Weather forecast for squeeze after r/s and PR coming. 1-3 is nothing but a good setup. 1/3 the shares to trade. Thin float coming. I usually sell on r/s announcements but not this one.

1 · Reply

SkyLonger Jul. 2 at 7:56 PM

$REVB S-1 now watch the buy backs come in toyal manipulation may be at 2$+ AH or tomorrow

0 · Reply

hassan101 Jul. 2 at 7:07 PM

$REVB U

0 · Reply

TwongStocks Jul. 2 at 6:15 PM

$REVB NASDAQ Equity Corporate Actions Alert # 2025 - 351 Information Regarding the Reverse Stock Split and CUSIP Number Change for Revelation Biosciences, Inc. (REVB) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-351 Revelation Biosciences, Inc. (REVB) will effect a one-for-three (1-3) reverse split of its Common Stock. The reverse stock split will become effective on Monday, July 7, 2025. In conjunction with the reverse split, the CUSIP number will change to 76135L705.

0 · Reply

hassan101 Jul. 2 at 2:38 PM

$REVB 🏹

0 · Reply

Fundy101 Jul. 2 at 2:13 PM

$REVB

0 · Reply

RetiredOldGeezer Jul. 2 at 2:04 PM

$REVB Looks like some painting the tape going on

1 · Reply

thaboss8854 Jul. 2 at 1:56 PM

$REVB $TPST some nice quiet period as we wait for news that can theoretically run them 15-50x. To a respetive market cap of 30m and speculative 1b$ (500m min).

0 · Reply

hassan101 Jul. 2 at 1:25 PM

$REVB 👀

0 · Reply

lookgoodplaygood22 Jul. 2 at 12:59 PM

$REVB this is why the split is only 1-3. It’ll actually make this scenario a low float and it’ll probably be heavily shorted. Do the math.

0 · Reply

Market Cap	3.50M
Revenue (ttm)	0.00
Net Income (ttm)	-15.04M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	367,500
Avg Vol	1,304,146
Day's Range	N/A - N/A
Shares Out	4.60M
Stochastic %K	21%
Beta	-0.08
Analysts	Strong Sell
Price Target	$20.73